After 50 years of research and the testing of over 1,000 drugs, there is new hope for preserving brain cells for a time after stroke. Treating acute ischemic stroke patients with an experimental neuroprotective drug, combined with a surgical procedure to remove the clot improves outcomes as shown by clinical trial results published today in The Lancet.
Challenging the US Food and Drug Administration's current approach to evaluating and approving adipose-based cell therapies used in reparative medicine, a group of researchers proposes a new path forward that focuses on patient safety and includes evidence-based medical practice.
EPO, an important drug for treating anemia, can now be produced in higher quantities and with better quality in mammalian cells designed using CRISPR.
Researchers at Karolinska Institutet in Sweden have carried out the first randomized trial of civilians with acute conflict-related wounds at two hospitals in areas affected by armed conflict. The study, which is published in The Lancet Global Health, shows that a new, more costly method of wound treatment is not more effective than standard treatment. The researchers hope to inspire new research projects in conflict zones that could improve the care for these vulnerable patients.
People aged 65 years and over are less likely to be readmitted to hospital if they are given help with their medication for three months after discharge, new research from the University of Bradford has found.
While fear memory -- or the ability to remember contexts in which to be afraid -- is important for survival, too much of it, and an inability to forget contexts that no longer apply, hinders daily activities. Recently, scientists from Japan found that a certain opioid drug can help mask some fear memory without causing undesirable side effects. This could make new therapies possible for anxiety disorders like phobias or PTSD.
The continuing epidemic of pre-term births includes this stark reality: tiny, fragile babies are born with underdeveloped lungs and prone to lifelong respiratory infections and related chronic illnesses. Researchers report new findings in Immunity that that will help in the development of new and cost effective methods to boost innate lung immunity in preterm babies.
Results from the NRG Oncology clinical study NRG-CC001 concluded that lowering radiotherapy dose to hippocampal stem cells improves cognitive and patient-reported outcomes for patients with brain metastases.
Danish and Norwegian researchers have moved one step closer to understanding where face blindness stems from in the brain. The condition affects approx. 2% of the population. Although we mainly use the right side of the brain to process visual impressions of faces, the research team has now discovered that an area in the back of the left side of the brain responds differently in people with face blindness.
The 2019 novel coronavirus (CoV) causes fatal pneumonia that has claimed over 1300 lives, with more than 52000 confirmed cases of infection by February 13, 2020, all in the span of just over a month. But, what is this virus? Is it a new virus altogether? Where did it come from? Scientists from top research institutes in China teamed up to answer these questions, and this pioneering study has been published in Chinese Medical Journal.